Margaret M. FitzPatrick, Director at AN2 Therapeutics, Inc. (ANTX), bought 2,098 shares at $5.53 ($12K) on 2026-09-01, disclosed to the SEC on 2026-09-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.